Table 1 Patient Characteristics.
From: Plasma PLTP activity is inversely associated with HDL-C levels
Characteristics†| PLTP* genotype (N) | p-value‡ | ||
|---|---|---|---|---|
| Â | gg (277) | gc(276) | cc(69) | Â |
Age (years) | 61.3 ± 10.5 | 63.3 ± 9.9 | 63.0 ± 9.4 | 0.06 |
Gender | Â | Â | Â | Â |
   Men (%) | 211(76.2) | 222(80.4) | 54(78.3) | 0.64 |
   Women (%) | 65(23.5) | 54(19.6) | 15(21.7) |  |
BMI§ (kg/m2) | 24.7 ± 2.9 | 24.5 ± 2.9 | 24.5 ± 3.2 | 0.55 |
Diabetes (%) | 56(20.21) | 51(18.5) | 11(15.9) | 0.69 |
Hypertension (%) | 171(61.7) | 175(63.4) | 23(33.3) | 0.77 |
Smoking (%) | 126(45.5) | 133(48.2) | 29(42.0) | 0.61 |
CHD|| (%) | 176(63.5) | 189(68.4) | 42(60.8) | 0.33 |
PLTP activity (pmol/μl/h) € | 23.7 ± 14.7 | 24.7 ± 14.0 | 26.7 ± 12.8 | 0.04 0.02 ††(cc vs gg) 0.26 ††(cc vs gc) 0.07 ††(gg vs gc) |
Total-C¶ (mmol/L) | 4.71 ± 0.96 | 4.41 ± 1.03 | 4.40 ± 0.99 | 0.74 |
TG# (mmol/L) | 1.74 ± 0.87 | 1.71 ± 1.08 | 1.8 ± 0.99 | 0.79 |
LDL-C (mmol/L) | 2.65 ± 0.85 | 2.60 ± 0.88 | 2.55 ± 0.89 | 0.67 |
HDL-C (mmol/L) | 1.03 ± 0.26 | 1.04 ± 0.29 | 1.01 ± 0.27 | 0.94 |
Low HDL-C (<0.8 mmol/L) (%) | 81(29.2) | 80(29.0) | 21(30.4) | 0.94 |
LDL-C/HDL-C | 2.74 ± 1.28 | 2.63 ± 0.99 | 2.71 ± 1.24 | 0.50 |
ApoA-I** (g/L) | 1.07 ± 0.19 | 1.06 ± 0.21 | 1.03 ± 0.21 | 0.18 |
apoB (g/L) | 0.82 ± 0.42 | 0.82 ± 0.42 | 0.79 ± 0.26 | 0.87 |
apoE (mg/L) | 47.99 ± 25.57 | 47.34 ± 18.39 | 45.17 ± 13.00 | 0.63 |
Lp(a)€ (mg/L) | 179.76 ± 157.41 | 202.89 ± 187.61 | 199.51 ± 227.73 | 0.30 |